Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19
Christiani, David C.
MetadataShow full item record
Summary in foreign language
Since December 2019, coronavirus disease 2019 (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a worldwide panic. Beyond the principal human-to-human transmission method by droplet and contact, there is still limited knowledge about possible alternate transmission methods to guide clinical care. Recent clinical studies have observed digestive symptoms in patients with COVID-19,1 possibly because of the enrichment and infection of SARS-CoV-2 in the gastrointestinal tract, mediated by virus receptor of angiotensin converting enzyme 2 (ACE2),2 which suggests the potential for a fecal-oral route of SARS-CoV-2 transmission.3,4 However, there is still a large gap in the biological knowledge of COVID-19. In this study, via a bulk-to-cell strategy focusing on ACE2, we performed an integrated omics analysis at the genome, transcriptome, and proteome levels in bulk tissues and single cells across species to decipher the potential routes for SARS-CoV-2 infection in depth.
Link to resourcehttps://www.gastrojournal.org/article/S0016-5085(20)30399-1/fulltext?referrer=https%3A%2F%2Fwww.google.com%2Furl%3Fsa%3DD%26q%3Dhttps%3A%2F%2Fdoi.org%2F10.1053%2Fj.gastro.2020.03.045%26ust%3D1596221460000000%26usg%3DAOvVaw18P95ZhqtROWurGV4y7C86%26hl%3Des
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.